Nazim Bozan

Prof. Dr. Nazim Bozan


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Journal of the Chinese Medical Association
Verified
Journal Article
Open access
NBNazim Bozan
Nazim Bozan
HDHalit Demir
Halit Demir
TGTülay Gürsoy
Tülay Gürsoy
HÖHüseyin Özkan
Hüseyin Özkan
UDUfuk Düzenli
Ufuk Düzenli
HÇHakan Çankaya
Hakan Çankaya
Data describing how laryngeal cancer affects oxidative stress markers and antioxidants are limited. This study investigated serum antioxidant enzyme activities and oxidative stress markers before and after laryngectomies in patients with laryngeal cancer. A total of 29 patients with laryngeal cancer and 25 healthy control subjects were enrolled. Serum malondialdehyde (MDA) levels and superoxide dismutase (SOD), glutathione peroxidase (GSHPx), catalase (CAT), paraoxonase (PON), and arylesterase activities were measured spectrophotometrically. Blood samples were obtained from each patient just before surgery and 1 month after a laryngectomy. The serum PON, arylesterase, CAT, SOD, and GSHPx activities were significantly decreased (all p < 0.001) and serum MDA levels were significantly increased (p < 0.001) in patients with laryngeal cancer, compared with control subjects. In laryngeal cancer patients, the serum GSHPx and arylesterase activity levels increased significantly following laryngectomies (both p < 0.001), whereas the MDA levels decreased significantly (p = 0.007). In patients with laryngeal cancer, the oxidant/antioxidant balance shifted toward oxidative stress. In addition, following laryngectomies, laryngeal cancer patients had increases in serum antioxidant enzyme activities and decreases in oxidative stress markers.

25 May 2022 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
BVBarbara Vona
Barbara Vona
DSD.A. Schwartzbaum
D.A. Schwartzbaum
ARA.A. Rodriguez
A.A. Rodriguez
SLS.S. Lewis
S.S. Lewis
MTM.B. Toosi
M.B. Toosi
SDS. Douzgou
S. Douzgou
Background: Pathogenic variants in KITLG, a crucial protein involved in pigmentation and neural crest cell migration, cause non‐syndromic hearing loss, Waardenburg syndrome type 2, familial progressive hyperpigmentation and familial progressive hyper‐ and hypopigmentation, all of which are inherited in an autosomal dominant manner.Objectives: To describe the genotypic and clinical spectrum of biallelic KITLG‐variants.Methods: We used a genotype‐first approach through the GeneMatcher data sharing platform to collect individuals with biallelic KITLG variants and reviewed the literature for overlapping reports.Results: We describe the first case series with biallelic KITLG variants; we expand the known hypomelanosis spectrum to include a ‘sock‐and‐glove‐like’, symmetric distribution, progressive repigmentation and generalized hypomelanosis. We speculate that KITLG biallelic loss‐of‐function variants cause generalized hypomelanosis, whilst variants with residual function lead to a variable auditory‐pigmentary disorder mostly reminiscent of Waardenburg syndrome type 2 or piebaldism.Conclusions: We provide consolidating evidence that biallelic KITLG variants cause a distinct auditory‐pigmentary disorder. We evidence a significant clinical variability, similar to the one previously observed in KIT‐related piebaldism.

1 November 2022 in Brazilian Journal of Otorhinolaryngology
Verified
Journal Article
Open access
YCYaser Said Cetin
Yaser Said Cetin
NBNazim Bozan
Nazim Bozan
KAKoray Avcı
Koray Avcı
MAMehmet Aslan
Mehmet Aslan
ÖEÖzcan EREL
Özcan EREL
Impaired cochlear perfusion is a major etiological factor in idiopathic sudden sensorineural hearing loss. Oxidative stress has been shown to be a risk factor for oxidative damage. We investigated the role of oxidative stress in idiopathic sudden sensorineural hearing loss by comparing serum levels of oxidant and antioxidant molecules including thiol/disulfide homeostasis paraoxonase, stimulated thiol/disulfide homeostasis paraoxonase, arylesterase, ceruloplasmin and myeloperoxidase in patients who did and did not recover after treatment. The amount of dynamic disulfide was calculated by determining half of the difference between the total thiols and native thiols. After the determination of native, total thiol, and disulfide amounts, the disulfide/total thiol percent ratio, native thiol/total thiol ratio and disulfide/native thiol percent ratio were calculated and then compared between the two groups. Additionally, clinical relationship between audiological recovery and native thiol, disulfide, disulfide/native thiol percent ratio, and disulfide/total thiol percent ratio levels was investigated. Blood samples were also analyzed for the assessment of thiol/disulfide homeostasis paraoxonase, stimulated thiol/disulfide homeostasis paraoxonase, arylesterase, ceruloplasmin, and myeloperoxidase levels. A significant difference was found between the two groups with regard to total oxidant status disulfide, disulfide/native thiol percent ratio, disulfide/total thiol percent ratio, and native thiol/total thiol ratio levels (p = 0.001, p = 0.001, p = 0.001, p = 0.003, p = 0.001, p = 0.002, respectively). However, no significant difference was found between the two groups with regard to thiol/disulfide homeostasis paraoxonase, stimulated thiol/disulfide homeostasis paraoxonase, ceruloplasmin, and myeloperoxidase levels (p > 0.05 for all). The results supported the common hypothesis that vascular pathologies are the primary cause of idiopathic sudden sensorineural hearing loss and that other etiological factors ultimately result in vascular pathologies. The oxidant-antioxidant and thiol-disulfide balances were impaired in the idiopathic sudden sensorineural hearing loss group.

28 September 2023 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
NBNazim Bozan
Nazim Bozan
ÖKÖmer Faruk Koçak
Ömer Faruk Koçak
CDCanser Yılmaz Demir
Canser Yılmaz Demir
KAKoray Avcı
Koray Avcı
ÖEÖmer Erdağ
Ömer Erdağ
HDHalit Demir
Halit Demir

12 April 2016 in The Journal of Membrane Biology
Verified
Journal Article
Closed access
PDF file
OKOmer Faruk Kocak
Omer Faruk Kocak
NBNazim Bozan
Nazim Bozan
MOMustafa Oksuz
Mustafa Oksuz
SYSerdar Yuce
Serdar Yuce
CDCanser Yılmaz Demir
Canser Yılmaz Demir
MRMurat Cetin Ragbetli
Murat Cetin Ragbetli

1 October 2018 in Ear, Nose & Throat Journal
Verified
Journal Article
Closed access
NBNazim Bozan
Nazim Bozan
ÖKÖmer Faruk Kocak
Ömer Faruk Kocak
CDCanser Yılmaz Demir
Canser Yılmaz Demir
MDMehmet Emre Dinc
Mehmet Emre Dinc
KAKoray Avcı
Koray Avcı
AKAhmet Faruk Kıroglu
Ahmet Faruk Kıroglu
We conducted a prospective study to comparatively evaluate serum levels of malondialdehyde, an oxidative stress indicator, and the antioxidant enzymes glutathione, catalase, and superoxide dismutase in patients with Bell palsy. Our study population was made up of 30 patients with Bell palsy—15 men and 15 women, aged 25 to 68 years (mean: 50.4)—who were seen in the Department of Otorhinolaryngology at a tertiary care medical center. For comparison purposes, we recruited 26 healthy age- and sex-matched controls—16 men and 10 women, aged 40 to 67 years (mean: 54.3). Serum samples were obtained from all participants before the initiation of steroid treatment to the Bell palsy patients. A correlation was sought between demographic data and serum levels of malondialdehyde, glutathione, catalase, and superoxide dismutase. We found that the serum level of malondialdehyde was significantly higher in the Bell palsy group and that the levels of glutathione, catalase, and superoxide dismutase were all significantly lower (p < 0.001 for all comparisons). Correlation analysis revealed that only superoxide dismutase levels were positively correlated with age (r = 0.347, p = 0.009). We suggest that oxidative stress and antioxidant mechanisms may be involved in the pathogenesis of Bell palsy. In this context, serum levels of malondialdehyde, glutathione, catalase, and superoxide dismutase may serve as biomarkers in the diagnosis and follow-up of Bell palsy. Confirmation of the validity, reliability, and reproducibility of these findings necessitates further prospective, randomized clinical trials in larger populations.